Skip to main content
. Author manuscript; available in PMC: 2022 Jan 25.
Published in final edited form as: Int J Pharm. 2020 Dec 2;593:120121. doi: 10.1016/j.ijpharm.2020.120121

Table 1.

Formulation parameters and designed particle composition by mass of the human inhalable vaccine candidates.

Component\Formulation T T20Leu T10Pul T20Pul T3Tri T6Tri

Feedstock Composition (mg/mL)
Leucine - 10.0 - - - -
Pullulan - - 4.5 10.5 - -
Trileucine - - - - 1.3 2.6
Trehalose 33.3 33.3 33.3 33.3 33.3 33.3
Tris (buffer) 0.807 0.807 0.807 0.807 0.807 0.807
Squalene 5.73 5.73 5.73 5.73 5.73 5.73
DMPC 1.27 1.27 1.27 1.27 1.27 1.27
GLA 0.0033 0.0033 0.0033 0.0033 0.0033 0.0033
ID93 0.0013 0.0013 0.0013 0.0013 0.0013 0.0013
Total Feed Concentration 41.1 51.1 45.6 51.6 42.4 43.7
Particle Composition (w/w)

Leucine - 20% - - - -
Pullulan - - 10% 20% - -
Trileucine - - - - 3% 6%
Trehalose 81% 65% 73% 65% 78% 76%
Tris (buffer) 2% 2% 2% 2% 2% 2%
Squalene 14% 11% 12% 11% 14% 13%
DMPC 3% 2% 3% 2% 3% 3%
GLA 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
ID93 0.003% 0.003% 0.003% 0.003% 0.003% 0.003%